Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 429

1.

[Preliminary efficacy of penetrating canaloplasty in primary angle-closure glaucoma].

Cheng HH, Hu C, Meng JY, Zhang SD, Lin SG, Bao JY, Xie YQ, Le RR, Ye C, Liang YB.

Zhonghua Yan Ke Za Zhi. 2019 Jun 11;55(6):448-453. doi: 10.3760/cma.j.issn.0412-4081.2019.06.008. Chinese.

PMID:
31189275
2.

Identification of Marek's disease virus genes associated with virulence of US strains.

Dunn JR, Black Pyrkosz A, Steep A, Cheng HH.

J Gen Virol. 2019 Jun 11. doi: 10.1099/jgv.0.001288. [Epub ahead of print]

PMID:
31184569
3.

The exploration of effect of terfenadine on Ca2+ signaling in renal tubular cells.

Cheng HH, Liang WZ, Kuo CC, Hao LJ, Chou CT, Jan CR.

J Recept Signal Transduct Res. 2019 Jun 11:1-7. doi: 10.1080/10799893.2019.1620777. [Epub ahead of print]

PMID:
31184240
4.

Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.

Paller CJ, Antonarakis ES, Beer TM, Borno HT, Carlo MI, George DJ, Graff JN, Gupta S, Heath EI, Higano CS, McKay RR, Morgans AK, Patnaik A, Petrylak DP, Rettig MB, Ryan CJ, Taplin ME, Whang YE, Vinson J, Cheng HH, Giri VN; PCCTC Germline Genetics Working Group.

Clin Genitourin Cancer. 2019 Apr 18. pii: S1558-7673(19)30139-9. doi: 10.1016/j.clgc.2019.04.013. [Epub ahead of print]

PMID:
31171481
5.

Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy.

Winters BR, De Sarkar N, Arora S, Bolouri H, Jana S, Vakar-Lopez F, Cheng HH, Schweizer MT, Yu EY, Grivas P, Lee JK, Kollath L, Holt SK, McFerrin L, Ha G, Nelson PS, Montgomery RB, Wright JL, Lam HM, Hsieh AC.

JCI Insight. 2019 May 30;5. pii: 128728. doi: 10.1172/jci.insight.128728.

6.

Genomic Characterization of Prostatic Ductal Adenocarcinoma Identifies a High Prevalence of DNA Repair Gene Mutations.

Schweizer MT, Antonarakis ES, Bismar TA, Guedes LB, Cheng HH, Tretiakova MS, Vakar-Lopez F, Klemfuss N, Konnick EQ, Mostaghel EA, Hsieh AC, Nelson PS, Yu EY, Montgomery RB, True LD, Epstein JI, Lotan TL, Pritchard CC.

JCO Precis Oncol. 2019;3. doi: 10.1200/PO.18.00327. Epub 2019 Apr 18.

7.

Socioeconomic Disparities of Depressive Symptoms and Cytokines in Hepatocellular Carcinoma.

Cheng HH, Kamarck TW, Gianaros PJ, Roecklein KA, Vanegas Y, Tsung A, Geller DA, Marsh JW, Ahmed NS, Steel JL.

Psychooncology. 2019 May 23. doi: 10.1002/pon.5127. [Epub ahead of print]

PMID:
31119824
8.

Germline and Somatic Mutations in Prostate Cancer for the Clinician.

Cheng HH, Sokolova AO, Schaeffer EM, Small EJ, Higano CS.

J Natl Compr Canc Netw. 2019 May 1;17(5):515-521. doi: 10.6004/jnccn.2019.7307. Review.

PMID:
31085765
9.

Distinguishing between carrier and noncarrier embryos with the use of long-read sequencing in preimplantation genetic testing for reciprocal translocations.

Chow JFC, Cheng HHY, Lau EYL, Yeung WSB, Ng EHY.

Genomics. 2019 Apr 1. pii: S0888-7543(18)30617-7. doi: 10.1016/j.ygeno.2019.04.001. [Epub ahead of print]

PMID:
30946890
10.

Mutations in the PKM2 exon-10 region are associated with reduced allostery and increased nuclear translocation.

Chen TJ, Wang HJ, Liu JS, Cheng HH, Hsu SC, Wu MC, Lu CH, Wu YF, Wu JW, Liu YY, Kung HJ, Wang WC.

Commun Biol. 2019 Mar 15;2:105. doi: 10.1038/s42003-019-0343-4. eCollection 2019.

11.

Clinical determinants for successful circulating tumor DNA analysis in prostate cancer.

Schweizer MT, Gulati R, Beightol M, Konnick EQ, Cheng HH, Klemfuss N, De Sarkar N, Yu EY, Montgomery RB, Nelson PS, Pritchard CC.

Prostate. 2019 May;79(7):701-708. doi: 10.1002/pros.23778. Epub 2019 Mar 13.

PMID:
30865311
12.

Metformin Affects Serum Lactate Levels in Predicting Mortality of Patients with Sepsis and Bacteremia.

Chen FC, Kung CT, Cheng HH, Cheng CY, Tsai TC, Hsiao SY, Wu CH, Su CM.

J Clin Med. 2019 Mar 6;8(3). pii: E318. doi: 10.3390/jcm8030318.

13.

Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations.

Marshall CH, Sokolova AO, McNatty AL, Cheng HH, Eisenberger MA, Bryce AH, Schweizer MT, Antonarakis ES.

Eur Urol. 2019 Feb 21. pii: S0302-2838(19)30110-1. doi: 10.1016/j.eururo.2019.02.002. [Epub ahead of print]

PMID:
30797618
14.

Time from definitive therapy to onset of metastatic disease predicts outcomes in men with metastatic hormone sensitive prostate cancer.

Hahn AW, Stenehjem DD, Alex AB, Gill DM, Cheng HH, Kessler ER, Chittoria N, Twardowski P, Vaishampayan U, Agarwal N.

Urol Oncol. 2019 Jun;37(6):352.e19-352.e24. doi: 10.1016/j.urolonc.2019.01.029. Epub 2019 Feb 13.

PMID:
30770300
15.

Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.

Carlo MI, Giri VN, Paller CJ, Abida W, Alumkal JJ, Beer TM, Beltran H, George DJ, Heath EI, Higano CS, McKay RR, Morgans AK, Patnaik A, Ryan CJ, Schaeffer EM, Stadler WM, Taplin ME, Kauff ND, Vinson J, Antonarakis ES, Cheng HH.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00060. Epub 2018 Aug 16.

16.

KDM4B is a coactivator of c-Jun and involved in gastric carcinogenesis.

Wu MC, Cheng HH, Yeh TS, Li YC, Chen TJ, Sit WY, Chuu CP, Kung HJ, Chien S, Wang WC.

Cell Death Dis. 2019 Jan 25;10(2):68. doi: 10.1038/s41419-019-1305-y.

17.

Free spectral range electrical tuning of a high quality on-chip microcavity.

Bekker C, Baker CG, Kalra R, Cheng HH, Li BB, Prakash V, Bowen WP.

Opt Express. 2018 Dec 24;26(26):33649-33670. doi: 10.1364/OE.26.033649.

PMID:
30650796
18.

Vaccination and Host Marek's Disease-Resistance Genotype Significantly Reduce Oncogenic Gallid alphaherpesvirus 2 Telomere Integration in Host Birds.

McPherson MC, Cheng HH, Smith JM, Delany ME.

Cytogenet Genome Res. 2018;156(4):204-214. doi: 10.1159/000495174. Epub 2018 Dec 21.

PMID:
30572327
19.

Prophylactic Transcatheter Arterial Embolization Helps Intraoperative Hemorrhagic Control for REMOVING Invasive Placenta.

Huang KL, Tsai CC, Fu HC, Cheng HH, Lai YJ, Hung HN, Tsang LL, Hsu TY.

J Clin Med. 2018 Nov 21;7(11). pii: E460. doi: 10.3390/jcm7110460.

20.

Manifestations and Outcomes of Patients with Parkinson's Disease and Serious Infection in the Emergency Department.

Su CM, Kung CT, Chen FC, Cheng HH, Hsiao SY, Lai YR, Huang CC, Tsai NW, Lu CH.

Biomed Res Int. 2018 Oct 17;2018:6014896. doi: 10.1155/2018/6014896. eCollection 2018.

21.

Anti-epileptic drugs associated with fractures in the elderly: a preliminary population-based study.

Cheng HH, Huang WC, Jeng SY.

Curr Med Res Opin. 2019 May;35(5):903-907. doi: 10.1080/03007995.2018.1541447. Epub 2018 Nov 23.

PMID:
30362853
22.

Genetic assessment of inbred chicken lines indicates genomic signatures of resistance to Marek's disease.

Xu L, He Y, Ding Y, Liu GE, Zhang H, Cheng HH, Taylor RL Jr, Song J.

J Anim Sci Biotechnol. 2018 Sep 13;9:65. doi: 10.1186/s40104-018-0281-x. eCollection 2018.

23.

Helicobacter pylori cholesterol glucosylation modulates autophagy for increasing intracellular survival in macrophages.

Lai CH, Huang JC, Cheng HH, Wu MC, Huang MZ, Hsu HY, Chen YA, Hsu CY, Pan YJ, Chu YT, Chen TJ, Wu YF, Sit WY, Liu JS, Chiu YF, Wang HJ, Wang WC.

Cell Microbiol. 2018 Dec;20(12):e12947. doi: 10.1111/cmi.12947. Epub 2018 Sep 17.

PMID:
30151951
24.

Inducing musical-interval learning by combining task practice with periods of stimulus exposure alone.

Little DF, Cheng HH, Wright BA.

Atten Percept Psychophys. 2019 Jan;81(1):344-357. doi: 10.3758/s13414-018-1584-x. Erratum in: Atten Percept Psychophys. 2019 Feb 21;:.

PMID:
30136042
25.

Correction: A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer.

Schweizer MT, Haugk K, McKiernan JS, Gulati R, Cheng HH, Maes JL, Dumpit RF, Nelson PS, Montgomery B, McCune JS, Plymate SR, Yu EY.

PLoS One. 2018 Aug 15;13(8):e0202709. doi: 10.1371/journal.pone.0202709. eCollection 2018.

26.

Quick Sepsis-related Organ Failure Assessment predicts 72-h mortality in patients with suspected infection.

Chen FC, Kung CT, Cheng HH, Cheng CY, Tsai TC, Hsiao SY, Su CM.

Eur J Emerg Med. 2018 Jul 25. doi: 10.1097/MEJ.0000000000000563. [Epub ahead of print]

PMID:
30048262
27.

Advanced diffusion imaging for assessing normal white matter development in neonates and characterizing aberrant development in congenital heart disease.

Karmacharya S, Gagoski B, Ning L, Vyas R, Cheng HH, Soul J, Newberger JW, Shenton ME, Rathi Y, Grant PE.

Neuroimage Clin. 2018 May 1;19:360-373. doi: 10.1016/j.nicl.2018.04.032. eCollection 2018.

28.

Diagnosis of Superficial Gastric Lesions Together with Six Gastric Lymphoma Cases via Probe-Based Confocal Laser Endomicroscopy: A Retrospective Observational Study.

Chen Q, Cheng HH, Deng S, Kuang D, Shu C, Cao L, Liao GQ, Guo QZ, Zhou Q.

Gastroenterol Res Pract. 2018 Jun 13;2018:5073182. doi: 10.1155/2018/5073182. eCollection 2018.

29.

Undetectable prostate-specific antigen after short-course androgen deprivation therapy for biochemically recurrent patients correlates with metastasis-free survival and prostate cancer-specific survival.

Lim DM, Gulati R, Aleshin-Guendel S, Gawne A, Wingate JT, Cheng HH, Etzioni R, Yu EY.

Prostate. 2018 Jul 10. doi: 10.1002/pros.23666. [Epub ahead of print]

PMID:
29987912
30.

Clinical significance of the BRAFV600E mutation in Asian patients with colorectal cancer.

Cheng HH, Lin JK, Chen WS, Jiang JK, Yang SH, Chang SC.

Int J Colorectal Dis. 2018 Sep;33(9):1173-1181. doi: 10.1007/s00384-018-3095-6. Epub 2018 Jun 4.

PMID:
29869121
31.

Sol-Gel Hydrothermal Synthesis and Visible Light Photocatalytic Degradation Performance of Fe/N Codoped TiO₂ Catalysts.

Cheng HH, Chen SS, Yang SY, Liu HM, Lin KS.

Materials (Basel). 2018 Jun 3;11(6). pii: E939. doi: 10.3390/ma11060939.

32.

Inhibition of retinal ganglion cell apoptosis: regulation of mitochondrial function by PACAP.

Cheng HH, Ye H, Peng RP, Deng J, Ding Y.

Neural Regen Res. 2018 May;13(5):923-929. doi: 10.4103/1673-5374.232489.

33.

A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer.

Schweizer MT, Haugk K, McKiernan JS, Gulati R, Cheng HH, Maes JL, Dumpit RF, Nelson PS, Montgomery B, McCune JS, Plymate SR, Yu EY.

PLoS One. 2018 Jun 1;13(6):e0198389. doi: 10.1371/journal.pone.0198389. eCollection 2018. Erratum in: PLoS One. 2018 Aug 15;13(8):e0202709.

34.

Restoration of hydroxyindole O-methyltransferase levels in human cancer cells induces a tryptophan-metabolic switch and attenuates cancer progression.

Chen HL, Yuan CY, Cheng HH, Chang TC, Huang SK, Kuo CC, Wu KK.

J Biol Chem. 2018 Jul 13;293(28):11131-11142. doi: 10.1074/jbc.RA117.000597. Epub 2018 May 24.

PMID:
29794137
35.

Pilot study of cold-rolling wastewater treatment using single-stage anaerobic fluidized membrane bioreactor.

Cheng HH, Whang LM, Yi TF, Liu CP, Lin TF, Yeh MS.

Bioresour Technol. 2018 Sep;263:418-424. doi: 10.1016/j.biortech.2018.04.124. Epub 2018 May 9.

PMID:
29772503
36.

Baicalin Ameliorates Imiquimod-Induced Psoriasis-Like Inflammation in Mice.

Hung CH, Wang CN, Cheng HH, Liao JW, Chen YT, Chao YW, Jiang JL, Lee CC.

Planta Med. 2018 Oct;84(15):1110-1117. doi: 10.1055/a-0622-8242. Epub 2018 May 15.

PMID:
29763944
37.

Biological acetate production from carbon dioxide by Acetobacterium woodii and Clostridium ljungdahlii: The effect of cell immobilization.

Cheng HH, Syu JC, Tien SY, Whang LM.

Bioresour Technol. 2018 Aug;262:229-234. doi: 10.1016/j.biortech.2018.04.069. Epub 2018 Apr 19.

PMID:
29709841
38.

MiR-221 inhibits proliferation of pancreatic cancer cells via down regulation of SOCS3.

Xie J, Wen JT, Xue XJ, Zhang KP, Wang XZ, Cheng HH.

Eur Rev Med Pharmacol Sci. 2018 Apr;22(7):1914-1921. doi: 10.26355/eurrev_201804_14714.

39.

Difference between elderly and non-elderly patients in using serum lactate level to predict mortality caused by sepsis in the emergency department.

Cheng HH, Chen FC, Change MW, Kung CT, Cheng CY, Tsai TC, Hsiao SY, Su CM.

Medicine (Baltimore). 2018 Mar;97(13):e0209. doi: 10.1097/MD.0000000000010209.

40.

Narrowing the wingless-2 mutation to a 227 kb candidate region on chicken chromosome 12.

Webb AE, Youngworth IA, Kaya M, Gitter CL, O'Hare EA, May B, Cheng HH, Delany ME.

Poult Sci. 2018 Jun 1;97(6):1872-1880. doi: 10.3382/ps/pey073.

41.

The resounding effect of DNA repair deficiency in prostate cancer.

Cheng HH.

Urol Oncol. 2018 Aug;36(8):385-388. doi: 10.1016/j.urolonc.2018.02.014. Epub 2018 Mar 17. Review.

PMID:
29555412
42.

GeSn resonant-cavity-enhanced photodetectors on silicon-on-insulator platforms.

Huang BJ, Lin JH, Cheng HH, Chang GE.

Opt Lett. 2018 Mar 15;43(6):1215-1218. doi: 10.1364/OL.43.001215.

PMID:
29543254
43.

Post-arrest therapeutic hypothermia in pediatric patients with congenital heart disease.

Cheng HH, Rajagopal SK, Sansevere AJ, McDavitt E, Wigmore D, Mecklosky J, Andren K, Williams KA, Danehy A, Soul JS.

Resuscitation. 2018 May;126:83-89. doi: 10.1016/j.resuscitation.2018.02.022. Epub 2018 Feb 21.

44.

Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International Study.

Mateo J, Cheng HH, Beltran H, Dolling D, Xu W, Pritchard CC, Mossop H, Rescigno P, Perez-Lopez R, Sailer V, Kolinsky M, Balasopoulou A, Bertan C, Nanus DM, Tagawa ST, Thorne H, Montgomery B, Carreira S, Sandhu S, Rubin MA, Nelson PS, de Bono JS.

Eur Urol. 2018 May;73(5):687-693. doi: 10.1016/j.eururo.2018.01.010. Epub 2018 Feb 8.

45.

Prostate cancer treated with reduced-volume intensity-modulated radiation therapy: Report on the 5-year outcome of a prospective series.

Luo HC, Fu ZC, Cheng HH, Lei Y, Liao SG, Feng J, Yin Q, Chen QH, Lin GS, Zhu JF, Xu JF, Dian W.

Medicine (Baltimore). 2017 Dec;96(52):e9450. doi: 10.1097/MD.0000000000009450.

46.

Antigen Analysis of Pre-Eclamptic Plasma Antibodies Using Escherichia Coli Proteome Chips.

Hsu TY, Lin JM, Nguyen MT, Chung FH, Tsai CC, Cheng HH, Lai YJ, Hung HN, Chen CS.

Mol Cell Proteomics. 2018 Aug;17(8):1457-1469. doi: 10.1074/mcp.RA117.000139. Epub 2017 Dec 28.

PMID:
29284593
47.

Circulating microRNAs and treatment response in the Phase II SWOG S0925 study for patients with new metastatic hormone-sensitive prostate cancer.

Cheng HH, Plets M, Li H, Higano CS, Tangen CM, Agarwal N, Vogelzang NJ, Hussain M, Thompson IM Jr, Tewari M, Yu EY.

Prostate. 2018 Feb;78(2):121-127. doi: 10.1002/pros.23452. Epub 2017 Nov 6.

48.

Probabilistic tractography-based thalamic parcellation in healthy newborns and newborns with congenital heart disease.

Jaimes C, Cheng HH, Soul J, Ferradal S, Rathi Y, Gagoski B, Newburger JW, Grant PE, Zöllei L.

J Magn Reson Imaging. 2018 Jun;47(6):1626-1637. doi: 10.1002/jmri.25875. Epub 2017 Oct 28.

49.

Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS RTOG).

Luo HC, Lin GS, Liao SG, Wang FM, Cheng HH, Feng J, Yin Q, Chen QH, Zhu JF, Xu JF, Wang D, Fu ZC.

Br J Radiol. 2018 Jan;91(1081):20170398. doi: 10.1259/bjr.20170398. Epub 2017 Dec 5.

50.

Hepatitis C infection and chemotherapy toxicity.

Ly A, Cheng HH, Alwan L.

J Oncol Pharm Pract. 2019 Mar;25(2):474-480. doi: 10.1177/1078155217734626. Epub 2017 Oct 11.

PMID:
29020856

Supplemental Content

Loading ...
Support Center